ストックスクリーナーアプリを入手
142.01
0.00%
0.0609
前日終値:
$141.95
開ける：
$141.05
24時間の取引高:
3.41M
Relative Volume:
0.48
時価総額：
$176.05B
収益：
$29.05B
当期純損益:
$8.11B
株価収益率:
22.00
EPS:
6.4563
ネットキャッシュフロー:
$9.16B
1週間 パフォーマンス:
+3.03%
1か月 パフォーマンス:
+16.74%
6か月 パフォーマンス:
+25.43%
1年 パフォーマンス:
+46.05%
1日の値動き範囲:
$140.01
$143.80
1週間の範囲:
$137.54
$143.80
52週間の値動き範囲:
$93.37
$143.80
Gilead Sciences Inc Stock (GILD) Company Profile
GILD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GILD
Gilead Sciences Inc
|
141.90 | 176.11B | 29.05B | 8.11B | 9.16B | 6.4563 |
|
LLY
Lilly Eli Co
|
1,053.00 | 928.27B | 59.42B | 18.41B | 6.44B | 20.22 |
|
AZN
Astrazeneca Plc
|
192.40 | 287.64B | 58.07B | 9.40B | 9.87B | 3.0115 |
|
JNJ
Johnson Johnson
|
229.46 | 547.51B | 94.19B | 26.80B | 20.46B | 11.05 |
|
ABBV
Abbvie Inc
|
224.65 | 394.14B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
150.31 | 285.29B | 54.45B | 14.42B | 17.15B | 7.333 |
Gilead Sciences Inc Stock (GILD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-07 | 再開されました | UBS | Buy |
| 2025-11-24 | 再開されました | Truist | Buy |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-08-19 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2025-08-08 | アップグレード | Truist | Hold → Buy |
| 2025-07-25 | アップグレード | Needham | Hold → Buy |
| 2025-04-22 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-03-04 | 繰り返されました | Oppenheimer | Outperform |
| 2025-02-18 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-02-13 | アップグレード | DZ Bank | Hold → Buy |
| 2025-01-10 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 再開されました | BofA Securities | Buy |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-11-14 | 開始されました | Citigroup | Buy |
| 2024-11-08 | ダウングレード | Maxim Group | Buy → Hold |
| 2024-10-21 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-10-17 | 開始されました | Bernstein | Outperform |
| 2024-10-07 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-07-08 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2024-05-01 | 繰り返されました | Maxim Group | Buy |
| 2024-04-24 | アップグレード | HSBC Securities | Reduce → Hold |
| 2024-02-22 | ダウングレード | Truist | Buy → Hold |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-09-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-09-06 | 開始されました | HSBC Securities | Reduce |
| 2023-07-24 | 繰り返されました | Barclays | Equal Weight |
| 2023-05-16 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-04-28 | 再開されました | Piper Sandler | Overweight |
| 2023-01-03 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-12-13 | 再開されました | BofA Securities | Neutral |
| 2022-12-09 | ダウングレード | DZ Bank | Buy → Hold |
| 2022-10-31 | アップグレード | Barclays | Underweight → Equal Weight |
| 2022-10-28 | 繰り返されました | BMO Capital Markets | Market Perform |
| 2022-10-28 | 繰り返されました | Cowen | Outperform |
| 2022-10-28 | 繰り返されました | JP Morgan | Overweight |
| 2022-10-28 | 繰り返されました | Jefferies | Buy |
| 2022-10-28 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-28 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-10-28 | アップグレード | Truist | Hold → Buy |
| 2022-10-28 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-10-04 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-07-13 | 開始されました | Cantor Fitzgerald | Neutral |
| 2022-05-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-02-28 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-02-02 | 繰り返されました | BMO Capital Markets | Outperform |
| 2022-02-02 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-02 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-02-02 | 繰り返されました | Truist | Hold |
| 2022-02-02 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-01-28 | アップグレード | Argus | Hold → Buy |
| 2022-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Neutral |
| 2021-11-19 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2021-11-19 | 再開されました | Piper Sandler | Neutral |
| 2021-10-20 | 再開されました | Cowen | Outperform |
| 2021-07-30 | 繰り返されました | BMO Capital Markets | Market Perform |
| 2021-07-30 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2021-04-01 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2021-03-30 | アップグレード | Redburn | Neutral → Buy |
| 2021-01-19 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-04 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-11-03 | 再開されました | Morgan Stanley | Equal-Weight |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-09-30 | 再開されました | Jefferies | Buy |
| 2020-09-15 | アップグレード | Maxim Group | Hold → Buy |
| 2020-07-31 | 繰り返されました | Credit Suisse | Neutral |
| 2020-07-31 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2020-07-31 | 繰り返されました | Piper Sandler | Overweight |
| 2020-07-31 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2020-07-31 | 繰り返されました | SunTrust | Hold |
| 2020-07-31 | 繰り返されました | Wells Fargo | Equal Weight |
| 2020-07-20 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2020-06-03 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2020-05-26 | アップグレード | SunTrust | Sell → Hold |
| 2020-05-01 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-05-01 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-05-01 | ダウングレード | SunTrust | Hold → Sell |
| 2020-04-27 | ダウングレード | UBS | Buy → Neutral |
| 2020-04-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2020-04-20 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | ダウングレード | CFRA | Hold → Sell |
すべてを表示
Gilead Sciences Inc (GILD) 最新ニュース
Implied Volatility Surging for Gilead Sciences Stock Options - TradingView
Gilead Sciences (NASDAQ:GILD) Sets New 12-Month High on Analyst Upgrade - MarketBeat
Synopsys, Rocket Companies, On Holding And A Health Care Stock On CNBC's 'Final Trades' - Benzinga
This Top Non-Tech AI Trade for 2026 Pays a Huge 11.6% Dividend - Investing.com
Gilead Sciences, Inc. $GILD Position Cut by TD Waterhouse Canada Inc. - MarketBeat
Atlantic Union Bankshares Corp Has $19.61 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Truist Securities Raises Price Target on Gilead Sciences, Inc. (GILD) to $145, Keeps Buy Rating - Yahoo Finance
Mediolanum International Funds Ltd Buys 9,971 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Thrivent Financial for Lutherans Boosts Stake in Gilead Sciences, Inc. $GILD - MarketBeat
AE Wealth Management LLC Buys 8,554 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences Rose 4% This Week. Here’s Where the Stock Could Be Headed in 2026 - TIKR.com
UBS Turns More Bullish on Gilead Sciences, Inc. (GILD) Amid Positive Pharma Sector Outlook - Finviz
10,471 Shares in Gilead Sciences, Inc. $GILD Acquired by Winnow Wealth LLC - MarketBeat
RWWM Inc. Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Purchased by Lingohr Asset Management GmbH - MarketBeat
Y Intercept Hong Kong Ltd Buys New Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (GILD) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Gilead Sciences stock hits all-time high at 141.74 USD - Investing.com
Leerink Partners Adjusts Gilead Sciences Price Target to $146 From $114, Maintains Outperform Rating - marketscreener.com
Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat
A Quick Look at Today's Ratings for Gilead Sciences(GILD.US), With a Forecast Between $145 to $154 - 富途牛牛
Leerink Partners raises Gilead Sciences stock price target to $146 on HIV pipeline - Investing.com
Knights of Columbus Asset Advisors LLC Purchases 27,260 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Patton Albertson Miller Group LLC Purchases Shares of 7,460 Gilead Sciences, Inc. $GILD - MarketBeat
Truist Financial Corp Has $34.45 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Holdings Lifted by Foundations Investment Advisors LLC - MarketBeat
Insider Sell: Daniel O'Day Sells 10,000 Shares of Gilead Sciences Inc (GILD) - GuruFocus
Gilead Sciences CEO O’Day sells $1.39 million in stock By Investing.com - Investing.com India
Gilead Sciences CEO O’Day sells $1.39 million in stock - Investing.com
Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 10,000 Shares of Stock - MarketBeat
Championing HIV Support in Italy Through Community-Based Checkpoints - Gilead Sciences
March 13th Options Now Available For Gilead Sciences (GILD) - Nasdaq
Truist Securities reiterates Buy rating on Gilead Sciences stock at $145 target - Investing.com
TD Cowen Adjusts Gilead Sciences Price Target to $145 From $125, Maintains Buy Rating - marketscreener.com
Wolfe Research Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - MarketBeat
Ruffer LLP Raises Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Are Wall Street Analysts Predicting Gilead Sciences Stock Will Climb or Sink? - Barchart.com
New York State Common Retirement Fund Sells 89,400 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Mirae Asset Global Investments Co. Ltd. Grows Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD is AustralianSuper Pty Ltd's 9th Largest Position - MarketBeat
Layoff Tracker: Gilead Continues California Cuts With 34 Laid Off - BioSpace
Gilead’s Trodelvy Win In TNBC Highlights Evolving Oncology Growth Story - Yahoo Finance
Gilead Oncology Momentum Builds As Trodelvy Data Meet Strong Share Gains - simplywall.st
Gilead stock dips as Medicare targets Biktarvy for 2028 price talks — and Trodelvy gets a guideline lift - TechStock²
Gilead’s Trodelvy added to NCCN guidelines - The Pharma Letter
Gilead Sciences to Release Fourth Quarter & Full Year 2025 Financial Results on Tuesday, February 10, 2026 - BioSpace
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Gilead price target raised to $145 from $140 at Truist - Yahoo Finance
These 4 Measures Indicate That Gilead Sciences (NASDAQ:GILD) Is Using Debt Reasonably Well - 富途牛牛
Federated Hermes Inc. Sells 324,814 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
AGP Franklin LLC Buys Shares of 11,148 Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences Inc (GILD) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.08%
大文字化:
|
ボリューム (24 時間):